Abbott’s tissue valves obtain FDA approval for mitral valve replacement

The US Food and Drug Administration (FDA) has approved Abbott’s Epic Plus and Epic Plus Supra Stented Tissue Valves to boost treatment options for individuals with aortic or mitral valve disease.